Amarin Corp Plc (AMRN)

[Ajax133]

Kiwi: Kudos to management for the bang up job they
did on the CC. It was upbeat, significant and pointed
toward an ability to get to R-IT results, and expand
the label. My only concern is that the clock may run
into 2018. I say that because of the initial enrollment
of low Trigs in the first 2000 patients. The event rate,
Power, and Hazard Ratio speak to the need for the required
8000 patients in the original design of the trial. Question,
when I occasionally visit this site, I see interim efficacy
numbers significantly higher than required for approval. How
are folks coming up with such great numbers ? I obviously
don't know the answer, but the numbers, if correct, will
rocket the stock. Congrats to you and all the longs who
hung in and endured a very bumpy ride. I believe Zum should
get credit for assiduously pumping out supportive information
that IMO prevented a mass exodus. I believe JL also had an
enormous positive influence. Kudos again.